Karsinomatosis Dokter Terbaik di Israel - TOP-10 dokter

Profesor Ofer Merimsky membawa lebih dari 25 tahun pengalaman onkologi, yang berspesialisasi dalam sarkoma dan tumor tulang di Sourasky Medical Center.

• Memimpin Unit Onkologi Jaringan Lunak dan Tulang
• Menjadi anggota Fakultas Sarkoma ESMO
• Menjalin kolaborasi penelitian ekstensif dengan Institut Weizmann dan Sekolah Sackler
• Mengajar onkologi di Universitas Tel-Aviv
• Berpartisipasi dalam uji klinis dan konferensi internasional

Dr. Pelles Sharon berspesialisasi dalam perawatan kanker tingkat lanjut, termasuk HIPEC untuk karsinomatosis, di Sourasky Medical Center.

• Ahli dalam Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Melakukan penelitian klinis tentang sikap pasien terhadap uji klinis kanker
• Menawarkan berbagai pilihan perawatan kanker bedah dan non-bedah

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Ari Raphael memimpin uji coba onkologi dan penelitian genomik di Sourasky Medical Center, yang berspesialisasi dalam kanker paru-paru dan payudara.

• Dosen senior di Fakultas Kedokteran Universitas Tel Aviv
• Peneliti utama untuk berbagai uji klinis pada NSCLC
• Ahli dalam biopsi cair dan profil genom komprehensif
• Moderator Molecular Tumor Board untuk Perkumpulan Kanker Paru-paru Israel
• Penerima hibah penelitian ISCORT dan penghargaan pengajaran

Kepala Departemen Bedah Kolorektal di Sourasky Medical Center. Beliau adalah spesialis terkemuka dengan pengalaman lebih dari 20 tahun.

• Ahli dalam bedah terbuka maupun invasif minimal
• Melakukan prosedur Whipple yang kompleks
• Fokus pada bedah perut dan kolorektal
• Pemimpin senior di rumah sakit besar di Israel

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.